Rating Change
Piper Sandler reiterated its Overweight rating on Cogent Biosciences, Inc. Common Stock (NASDAQ:COGT) on August 17, 2026.
reiterateNASDAQ:COGT
Piper Sandler Reiterates Overweight Rating on Cogent Biosciences, Inc. Common Stock (COGT)
Piper Sandler reiterated its Overweight rating on Cogent Biosciences, Inc. Common Stock (NASDAQ:COGT) on August 17, 2026.
At publication ·
What changed
Cogent Biosciences, Inc. Common Stock (NASDAQ:COGT) · reiterate
- Firm
- Piper Sandler
- Rating
- Overweight to Overweight
- Price at event
- $37.87
- Market capitalization
- $5.7B
At a glance
Key takeaways
- Piper Sandler reiterated an Overweight rating on Cogent Biosciences (COGT) on August 17, 2026, with the stock trading at $37.87 and a market capitalization of $5.7 billion.
Market Context
Cogent Biosciences, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $37.87 with a market capitalization of $5.7B. The stock has gained 216.6% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Cogent Biosciences, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Cogent Biosciences, Inc. Common Stock
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | Piper Sandler | Overweight | N/A |
| Aug 12, 2026 | Guggenheim | Buy | N/A |
| May 29, 2026 | Wedbush | Outperform | N/A |
| May 06, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 17, 2026 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View COGT Stock Page
Frequently Asked Questions
What does the Overweight rating mean for COGT?
A rating of Overweight from Piper Sandler reflects the analyst's outlook on Cogent Biosciences, Inc. Common Stock (NASDAQ:COGT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the COGT forecast page.